Form D · Other Investment Fund
ALPHYN BIOLOGICS INVESTORS LLC
Norwood, OH · CIK 0002011198
Offering snapshot reported Aug 6, 2025 · SEC filing
- Reported sold
- $7.27M Offering amount: $9.9M
- Investors reported
- 101 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 22, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 101
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 6, 2025 | Amendment | $7,267,500 | No comparison | 101 | SEC filing |
| Feb 9, 2024 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-504829
Source: Form D, filed Aug 6, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Habbert | Director |
| Tony L. Shipley | Director |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
1775 Mentor Avenue, Suite 203
Norwood, OH, 45212
Norwood, OH, 45212